Answers are grounded in this paper and cite their sources.
Our study identifies reduced angiogenin ( Ang) expression in the ventral midbrain (VMB) of MC1Re/e mice, validated through RNA-seq, RT-qPCR, and Western blot. This CNS-specific downregulation suggests localized regulatory mechanisms linked to neuroprotection and Parkinson’s disease (PD) pathogenesis. Ang’s role in neurodegeneration, angiogenesis, and oxidative stress responses highlights its therapeutic potential in PD. These findings provide critical insights into Ang’s CNS-specific function and underscore the importance of further research into its mechanistic role in PD.
No takes yet. Share an insight, caveat, or question.
Aye et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: